From this CPD module you will learn about:
- The conditions that NOACs are indicated for
- The advice you should give if patients forget to take a dose or take too much
- Safety aspects and interactions for NOACs
- The recommended process for switching from warfarin to a NOAC and vice versa
Download a printable PDF of this module – including the five-minute test – here.
There are four non-vitamin K antagonist oral anticoagulants (NOACs) – apixaban (Eliquis), dabigatran etexilate (Pradaxa), edoxaban (Lixiana) and rivaroxaban (Xarelto).(1-4) Unlike warfarin, which works by inhibiting clotting factors that are dependent on vitamin K, the majority of NOACs act by inhibiting factor Xa (a protein that converts prothrombin to the key clotting factor thrombin). This then prevents the development of a clot. One